The clinical, morphologic, and molecular changes in the ileum associated with early postnatal dexamethasone administration: From the baby's bowel to the researcher's bench

Molecular Genetics and Metabolism

Volumn 72, Issue 2, 2001, Pages 91-103

  Gordon, Phillip V ^a   Marshall, Diane D ^b   Stiles, Alan D ^b   Price, Wayne A ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Dexamethasone; Focal small bowel perforation; Ileum; Indomethacin; Insulin like growth factor

Indexed keywords

DEXAMETHASONE; SOMATOMEDIN;

ANIMAL CELL; ANIMAL EXPERIMENT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; GESTATIONAL AGE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; ILEUM MUCOSA; IMMUNOLOCALIZATION; INFANT; INTESTINE MUSCLE; INTESTINE PERFORATION; MOUSE; NEWBORN; NONHUMAN; PATHOGENESIS; PERINATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SHORT SURVEY;

ANIMALIA;

EID: 0035718502     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.2000.3127     Document Type: Article

References (94)

1. A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: A randomized trial
2. Serious complications of in a randomized trial of early stress dose dexamethasone (DEX) in extremely low birth weight (ELBW) infants
3. Early postnatal dexamethasone therapy for the prevention of chronic lung disease
4. Early dexamethasone - Attempting to prevent chronic lung disease
5. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: Outcome study participants at 1-year adjusted age
6. Early dexamethasone therapy in preterm infants: A follow-up study
7. Early postnatal dexamethasone increases the risk of focal small bowel perforation in extremely low birth weight infants
8. The etiology of gastrointestinal perforations in the newborn
9. Neonatal intestinal perforation caused by congenital defects of the intestinal musculature
10. Neonatal intestinal perforation due to congenital defects in the intestinal muscularis
11. Absent intestinal musculature: Anatomic evidence of embryonic origin of the lesion
12. Spontaneous focal gastrointestinal perforation in very low birth weight infants
13. Intestinal perforations in infants with a very low birth weight: A disease of increasing survival?
14. Indomethacin-associated bowel perforations: A study of possible risk factors
15. Intestinal perforation associated with indomethacin treatment in premature infants
16. Localized intestinal perforation after enteral administration of indomethacin in premature infants
17. Clinical comparison of localized intestinal perforation and necrotizing enterocolitis in neonates
18. Upper and lower gastrointestinal complications with dexamethasone despite H2 antagonists
19. Lower gastrointestinal tract perforation in preterm infants treated with dexamethasone for bronchopulmonary dysplasia
20. Focal gastrointestinal perforations not associated with necrotizing enterocolitis in very low birth weight neonates
21. Focal intestinal perforation in preterm infants is an emerging disease
22. Focal intestinal perforation in the extremely-low-birth-weight infant
23. Acute indomethacin-induced jejunal injury in the rat: Early morphological and biochemical changes
24. Vascular anatomy defines sites of indomethacin induced jejunal ulceration along the mesenteric margin
25. Influences of dexamethasone on the maturation of fetal mouse intestinal mucosa in organ culture
26. Dexamethasone administration to newborn mice alters mucosal and muscular morphology in the ileum and modulates insulin-like growth factor (IGF) I localization
27. Studies of normal and precocious appearance of jejunal sucrase in suckling rats
28. Otogeny of the intestinal mucosa
29. A study of the cytoplasmic receptors for glucocorticoids in intestine of pre- and postweanling rats
30. Differential expression of fos and jun family members during murine postnatal intestinal development
31. Negative regulation of glucocorticoid-dependent induction of c-fos by ras in intestinal epithelial cells
32. Dexamethasone protection of rat intestinal epithelial cells against oxidant injury is mediated by induction of heat shock protein 72
33. Organ culture of fetal rat intestine. Effects on brush border enzyme activities of the combined administration of dexamethasone and cyclohexamide or actinomycin D
34. Immunochemical studies of intestinal disaccharidases during normal and precocious development
35. Ontogeny of sucrase-ios-maltase gene expression in rat intestine: Responsiveness to glucocorticoids
36. Organ culture of suckling rat intestine: Comparative study of various hormones on brush border enzymes
37. Effect of prenatal dexamethasone administration: Feat rabbit intestinal nutrient uptake and disaccharidase development
38. Isolation and characterization of the human sucrase-isomaltase gene and demonstration of intestinal-specific transcriptional elements
39. Glucocorticoids have pleotropic effects on small intestinal crypt cells
40. Role of glucocorticoids on the maturation of brush border enzymes in fetal rat gut endoderm
41. Fetal gut mesenchyme induces differentiation of cultured intestinal endodermal and crypt cells
42. Mesenchymal-mediated effect of dexamethasone on laminin in co-cultures of embryonic gut epithelial cells and mesenchyme-derived cells
43. Tenascin during gut development: Appearance in the mesenchyme, a shift in molecular forms, and dependence on epithelial-mesenchymal interactions
44. Prevention of necrotizing enterocolitis in the rat with prenatal cortisone
45. Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: A controlled trial
46. Prolactin, alone or in combination with glucocorticoids, enhances tight junction formation and expression of the tight junction protein occludin in mammary cells
47. Glucocorticoids regulate transepithelial fluid flow resistance and formation of intercellular junctions
48. Acute stress causes mucin release from rat colon: Role of corticotropin releasing factor and mast cells
49. Transcriptional and post-translational regulation of the meprin beta metalloproteinase subunit in human and mouse cancer cells
50. Meprin mRNA in rat intestine during normal and glucocorticoid-induced maturation: Divergent patterns of expression of alpha and beta subunits
51. Dexamethasone inhibits small intestinal growth via increase protein catabolism in neonatal pigs
52. Corticosterone has independent effects on tissue maturation and growth in the suckling rat
53. IGFs and the digestive tract
54. Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth factor I
55. Oral insulin-like growth factor-I stimulates intestinal enzyme maturation in newborn rats
56. Small intestinal disaccharidase activity and ileal villus height are increased in piglets consuming formula containing recombinant human insulin-like growth factor I
57. Regulation of types I, III, and IV procollagen mRNA synthesis in glucocorticoid-mediated intestinal development
58. Corticosteroids increase procollagen gene expression, synthesis, and secretion by human intestinal smooth muscle cells
59. Epidermal growth factor selectively increases maltase and sucrase activities in neonatal piglet intestine
60. Epidermal growth factor upregulates intestinal electrolyte and nutrient transport
61. Biologic effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: An update
62. Epidermal growth factor in human and bovine milk
63. Radiographic localization of epidermal growth factor receptors in human fetal gut
64. Milk-borne epidermal growth factor modulates intestinal transforming growth factor-α levels in neonatal rats
65. The role of insulin-like growth factors in small intestinal cell growth and development
66. IGF-I and the truncated analogue des-(1-3) IGF-I enhance growth in rats after gut resection
67. GH elevates serum IGF-I levels but does not alter mucosal atrophy in parentally fed rats
68. Increase in insulin like growth factor I in hypertrophying smooth muscle
69. Cyclic stretch regulates autocrine IGF-I in vascular smooth muscle cells: Implications for vascular hyperplasia
70. Targeted over expression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle tissue beds of transgenic mice
71. Insulin-like growth factors I and II and their binding proteins in rat milk
72. Insulin-like growth factors and insulin-like growth factor binding proteins in porcine serum and milk throughout lactation
73. 3 insulin-like growth factor I promote intestinal growth of newborn rat pups
74. Bioactive molecules in milk and their role in health and disease1: The role of transforming growth factor-beta
75. Hepatocyte growth factor in human breast milk
76. Localization of transforming growth factor-beta receptor types I, II, and III in the postnatal rat small intestine
77. Effects of growth factors on an intestinal epithelial cell line: Transforming growth factor beta inhibits proliferation and stimulates differentiation
78. Cytokine modulation of intestinal epithelial cell restitution: Central role of transforming growth factor beta
79. Developmental expression and functionality of hepatocyte growth factor and c-Met in human fetal digestive tissues
80. Epidermal and hepatocyte growth factors stimulate chemotaxis in an intestinal epithelial cell line
81. Hepatocyte growth factor activator: A possible role for morphogenesis during fetal development of the rat gastrointestinal tract
82. Hepatocyte growth factor accelerates the wound repair of cultured gastric mucosal cells
83. Expression of platelet-derived growth factor beta receptor during organogenesis and tissue differentiation in the mouse embryo
84. Platelet-derived growth factor accelerates gastric epithelial restoration in a rabbit cultured cell model
85. Mechanism of action and in vivo role of platelet-derived growth factor
86. Insulin-like growth factors and their binding proteins: Biologic actions
87. The insulin like growth factor-binding protein (IGFBP) super family
88. IGFBP-5 (201-218) stimulates Cdc42GAP aggregation and filopodia formation in migrating mesangial cells
89. Insulin-like growth factors and insulin-like growth factor binding proteins in porcine serum and milk throughout lactation
90. Identification of IGF binding proteins in bovine milk and the demonstration of IGFBP-3 synthesis and release by bovine mammary epithelial cells
91. Insulin-like growth factor (IGF) system in the bovine mammary gland and milk
92. Is milk-borne insulin-like growth factor-I essential for neonatal development?
93. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants
94. Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome